201
|
Yang P, Zhen JF, Pang M, Hu K, Zhao W, Dong F, Tian L, Ke XY, Jing HM. [Analysis of survival and treatment outcome of patients with primary diffuse large B cell lymphoma in reproductive system]. Zhonghua Yi Xue Za Zhi 2018; 98:1593-1596. [PMID: 29886651 DOI: 10.3760/cma.j.issn.0376-2491.2018.20.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze clinical feature and treatment outcome of patients with primary diffuse large B cell lymphoma(DLBCL) in reproductive system. Methods: A total of 26 patients with DLBCL in reproductive system were retrospectively analyzed, and the clinical features, laboratory data were included in Kaplan-Meier and prognostic analysis. Results: In our center, the incidence of primary diffuse large B cell lymphoma in reproductive system was 3.5% in all DLBCL patients, and the median age was 62.0 years. Male are more common with unilateral testicular involvement, and 38.5% patients belong to Ⅲ and Ⅳstage while 84.6% patients belong to non-germinal center B cell-like subgroup. The overall response rate(ORR) for the whole group was 88.5%. The complete response rate was 76.9%. The 3, 5-year progression free survival rate was 70.5% and 62.7% , and the 3, 5-year overall survival rate was 83.5% and 69.6%, respectively. The most common recurrent sites were contralateral testis and central nervous system. Rituximab can improve the survival of patients and combined with contralateral irradiation can furtherly improve progression free survival of patients(P=0.047). Clinical stage, B symptom, IPI, the level of LDH, and CRP, age>60 years, and initial treatment outcome were predictive of overall survival. Conclusion: Primary diffuse large B cell lymphoma in reproductive system is a rare type of extranodal DLBCL which occurs in older men with aggressive features. The most common sites of recurrence were contralateral testis and central nervous system. Surgery, rituximab , radiotherapy and prophylactic intrathecal injection can improve the survival of patients and may be the first-line treatment.
Collapse
Affiliation(s)
- P Yang
- Department of Hematology, the Third Hospital of Peking University, Beijing 100191, China
| | | | | | | | | | | | | | | | | |
Collapse
|
202
|
Lim SH, Hong JY, Lim ST, Hong H, Arnoud J, Zhao W, Yoon DH, Tang T, Cho J, Park S, Ko YH, Kim SJ, Suh C, Lin T, Kim WS. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. Ann Oncol 2018; 28:2199-2205. [PMID: 28911074 DOI: 10.1093/annonc/mdx316] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Background Current standard treatment, including non-anthracycline-based chemotherapy and optimal combining of radiotherapy, has dramatically improved outcomes of patients with extranodal natural killer/T-cell lymphoma (ENKTL) during the last decade. This study was conducted to investigate the clinical outcome of ENKTL patients with relapsed or progressive disease after initial current standard therapy. Patients and methods We retrospectively reviewed patients diagnosed with ENKTL at six centers in four countries (China, France, Singapore, and South Korea) from 1997 to 2015 and analyzed 179 patients who had relapsed or progressed after initial current standard therapy. Results After a median follow-up of 58.6 months (range 27.9-89.2), the median second progression-free survival (PFS) was 4.1 months [95% confidence interval (CI) 3.04-5.16] and overall survival (OS) was 6.4 months (95% CI 4.36-8.51). Multivariate Cox-regression analysis revealed that elevated lactate dehydrogenase, multiple extranodal sites (≥2), and presence of B symptoms were associated with inferior OS (P < 0.05). OS and PFS were significantly different according to both prognostic index of natural killer lymphoma (PINK) and PINK-E (Epstein-Barr virus) models. Salvage chemotherapy with l-asparaginase (l-Asp)-based regimens showed a significantly better clinical benefit to response rate and PFS, although it did not lead to OS improvement. First use of l-Asp in the salvage setting and l-Asp rechallenge at least 6 months after initial treatment were the best candidates for salvage l-Asp containing chemotherapy. Conclusions Most patients with relapsed or refractory ENKTL had poor prognosis with short survival. Further studies are warranted to determine the optimal treatment of patients with relapsed or refractory ENKTL.
Collapse
Affiliation(s)
- S H Lim
- Division of Hematology-Oncology, Department of Internal Medicine, Soon Chun Hyang University, Bucheon Hospital, Bucheon-si.,Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul
| | - J Y Hong
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S T Lim
- Division of Medical Oncology, National University Cancer Institute, Singapore
| | - H Hong
- State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China
| | - J Arnoud
- Department of Hematology, CHU, Limoges, France
| | - W Zhao
- State Key Laboratory of Medical Genomics, Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - D H Yoon
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - T Tang
- Division of Medical Oncology, National University Cancer Institute, Singapore
| | - J Cho
- Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul
| | - S Park
- Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul
| | - Y H Ko
- Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - S J Kim
- Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul
| | - C Suh
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - T Lin
- State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China
| | - W S Kim
- Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul
| |
Collapse
|
203
|
Du L, Gu T, Zhang Y, Huang Z, Wu N, Zhao W, Chang G, Xu Q, Chen G. Transcriptome profiling to identify key mediators of granulosa cell proliferation upon FSH stimulation in the goose (Anser cygnoides). Br Poult Sci 2018; 59:416-421. [PMID: 29723039 DOI: 10.1080/00071668.2018.1459474] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
1. The low reproductive performance of geese has seriously hampered the development of the industry. Reproductive performance, particularly the egg laying rate mainly depends on the development of the follicle. Previous studies have shown that follicle-stimulating hormone (FSH) plays an important role in the process of follicular development, but the exact underlying mechanism remains unclear. 2. This study showed that FSH stimulated granulosa cell proliferation in a dose-dependent manner. The effect of FSH treatment on granulosa cell proliferation was greatest at a dose of 100 mIU/ml FSH for 24 h. 3. Secondly, the effect of different concentrations of FSH on goose granulosa cell proliferation was investigated, and de novo transcriptome assembly and gene expression analysis performed using short-read sequencing technology (Illumina). High-throughput sequencing results yielded 62.61 M reads and 7.8 G base pairs from granulosa cells treated with 100 mIU/ml FSH. These reads were assembled into 65,757 unigenes (mean length: 705 bp) with an N50 of 903 bp. A total of 110 upregulated and 510 downregulated differentially expressed genes (DEGs) were identified by RNA-seq. 4. Functional analysis by gene ontology (GO) and KEGG pathway annotation indicated that hormone biosynthesis (GO:0042446), positive regulation of hormone secretion (GO:0046887), steroid biosynthesis, oxidative phosphorylation and carbon metabolism pathways were involved in FSH-mediated proliferation of goose granulosa cells. 5. After screening, a group of key responsive genes including superoxide dismutase 1, fatty acyl-CoA reductase 1, transforming growth factor-beta receptor-associated protein 1 and follistatin were tested by real-time reverse transcription PCR to confirm differential expression in granulosa cells stimulated by FSH. 6. FSH-stimulated goose granulosa cells and DEG profiling data provided comprehensive gene expression information at the transcriptional level that could promote better understanding of the molecular mechanisms underlying follicle development in response to FSH stimulation.
Collapse
Affiliation(s)
- L Du
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - T Gu
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - Y Zhang
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - Zhengyang Huang
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - N Wu
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - W Zhao
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - G Chang
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - Q Xu
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| | - G Chen
- a Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education , Yangzhou University , Yangzhou , PR China
| |
Collapse
|
204
|
Chen L, Zhao W, Zhong G, Watts C, Gunn JP, Liu X, Lian Y, DLP Team. Thermal Analysis on Various Design Concepts of ITER Divertor Langmuir Probes. Fusion Science and Technology 2018. [DOI: 10.1080/15361055.2017.1415614] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- L. Chen
- Southwestern Institute of Physics, Chengdu, Sichuan 610025, China
| | - W. Zhao
- Southwestern Institute of Physics, Chengdu, Sichuan 610025, China
| | - G. Zhong
- Southwestern Institute of Physics, Chengdu, Sichuan 610025, China
| | - C. Watts
- ITER Organization, Route de Vinon-sur-Verdon, CS 90046, 13067 St. Paul Lez Durance Cedex, France
| | | | - X. Liu
- Southwestern Institute of Physics, Chengdu, Sichuan 610025, China
| | - Y. Lian
- Southwestern Institute of Physics, Chengdu, Sichuan 610025, China
| | - DLP Team
- Southwestern Institute of Physics, Chengdu, Sichuan 610025, China
| |
Collapse
|
205
|
Luo L, Chen T, Li Z, Zhang Z, Zhao W, Fan M. Heteroatom self-doped activated biocarbons from fir bark and their excellent performance for carbon dioxide adsorption. J CO2 UTIL 2018. [DOI: 10.1016/j.jcou.2018.03.014] [Citation(s) in RCA: 47] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
206
|
Qin HY, Zhao WX, Zhao W, Zhang C, Feng XQ, Liu SP, Wang KG. Parametric investigations on the saturation intensity of Coumarin 102 for stimulated emission depletion application. J Microsc 2018; 271:136-144. [PMID: 29683482 DOI: 10.1111/jmi.12703] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2017] [Revised: 03/15/2018] [Accepted: 03/21/2018] [Indexed: 11/29/2022]
Abstract
Stimulated emission depletion (STED) microscopy performed using continuous-wave (CW) lasers has been investigated and developed by Willig et al. (Nature Methods, 2007, 4(11):915) for nearly a decade. Kuang et al. (Review of Scientific Instruments, 2010, 81:053709) developed the CW STED microscopy technique with 405 nm excitation and 532 nm depletion beams. In their research, Coumarin 102 dye was adopted and was found to be depletable. In this study, a parametric investigation of the depletion of Coumarin 102 dye is carried out experimentally. The influence of the excitation and depletion beam intensities and dye concentrations on the depletion efficiency are studied in detail. The results indicate the following: (1) The highest depletion occurs for the 100 μM Coumarin 102 solution, with a 1.4 μW excitation beam and a 115.3 mW depletion beam. (2) The minimum saturation intensity (Is) of STED, that is 13 MW cm-2 , is observed when the Coumarin 102 solution concentration is 10 μM. (3) Is values calculated directly from the depletion power derived with the cross-sectional area due to the full-width-at-half-maximum (FWHM) of the depletion beam show poor accuracy, where Is may be overestimated. Thus, a correction factor for the cross-sectional area is proposed. We also find that Is is not exactly constant for a fixed excitation beam power and dye concentration. This trend indicates that the conventional suppression function η(x)=e- ln (2)ISTED(x)/Is derived from picosecond STED may cause errors in evaluating the depletion process in CW STED microscopy.
Collapse
Affiliation(s)
- H-Y Qin
- State Key Laboratory of Cultivation Base for Photoelectric Technology and Functional Materials, Laboratory of Optoelectronic Technology of Shaanxi Province, National Center for International Research of Photoelectric Technology & Nano-functional Materials and Application, Institute of Photonics and Photon-Technology, Northwest University, Xi'an, China
| | - W-X Zhao
- State Key Laboratory of Cultivation Base for Photoelectric Technology and Functional Materials, Laboratory of Optoelectronic Technology of Shaanxi Province, National Center for International Research of Photoelectric Technology & Nano-functional Materials and Application, Institute of Photonics and Photon-Technology, Northwest University, Xi'an, China
| | - W Zhao
- State Key Laboratory of Cultivation Base for Photoelectric Technology and Functional Materials, Laboratory of Optoelectronic Technology of Shaanxi Province, National Center for International Research of Photoelectric Technology & Nano-functional Materials and Application, Institute of Photonics and Photon-Technology, Northwest University, Xi'an, China
| | - C Zhang
- State Key Laboratory of Cultivation Base for Photoelectric Technology and Functional Materials, Laboratory of Optoelectronic Technology of Shaanxi Province, National Center for International Research of Photoelectric Technology & Nano-functional Materials and Application, Institute of Photonics and Photon-Technology, Northwest University, Xi'an, China
| | - X-Q Feng
- State Key Laboratory of Cultivation Base for Photoelectric Technology and Functional Materials, Laboratory of Optoelectronic Technology of Shaanxi Province, National Center for International Research of Photoelectric Technology & Nano-functional Materials and Application, Institute of Photonics and Photon-Technology, Northwest University, Xi'an, China
| | - S-P Liu
- Chinese Academy of Sciences, Suzhou Institute of Biomedical Engineering and Technology, Suzhou, China
| | - K-G Wang
- State Key Laboratory of Cultivation Base for Photoelectric Technology and Functional Materials, Laboratory of Optoelectronic Technology of Shaanxi Province, National Center for International Research of Photoelectric Technology & Nano-functional Materials and Application, Institute of Photonics and Photon-Technology, Northwest University, Xi'an, China
| |
Collapse
|
207
|
Wang YP, Yao SH, Liu D, Shen T, Zhao W, Gao W, Xu SL. [Relationships between percentage of skeletal muscle mass and cardiorespiratory fitness in elderly patients with coronary heart disease]. Zhonghua Yi Xue Za Zhi 2018; 98:831-836. [PMID: 29609265 DOI: 10.3760/cma.j.issn.0376-2491.2018.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To determine the relative percentage of skeletal muscle mass (SMM) in elderly patients with coronary heart disease, analyse the relationship between percentage of SMM and cardiorespiratory fitness (CRF), predict exercise capacity and cardiac reserve. Methods: Patients aged 65 years and over after PCI, receiving cardiopulmonary exercise testing (CPET) during February 2014 to December 2016 in Department of Cardiology at Peking University Third Hospital were enrolled.All patients' basic data, percentage of SMM and CPET related parameters, including peak oxygen uptake (VO(2)peak), oxygen pulse (VO(2)/HR), oxygen uptake efficiency slope (OUES) and other cardiorespiratory endurance indicators were collected, to do correlation analysis. Results: There were 402 patients enrolled, with average age (71±5) years, including 283 cases of male (70.40%) and 119 cases of female patients (29.60%). There were 62 patients with acute myocardial infarction (15.42%), 113 patients with old myocardial infarction (28.11%), and 227 patients diagnosed with angina pectoris (56.47%). The percentage of SMM was correlated to CRF.The percentage of SMM[97.00 (92.05, 102.10)%] and VO(2)/HR (r=0.231, P<0.001) and OUES (r=0.264, P<0.001) were positively correlated.Body mass index was negatively correlated with VO(2)peak(r=-0.162, P=0.001). Visceral fat area (VFA) was also negatively correlated with VO(2)peak(r=-0.126, P=0.016). Multiple linear regression analysis showed that Body mass index and VFA were negatively correlated with VO(2)peak (r=-0.204, P=0.014; r=-0.031, P=0.013). The percentage of SMM was positively independently correlated with OUES(r=11.020, P<0.001). Conclusions: Muscle content is positively correlated with exercise capacity of patients.The percentage of skeletal muscle mass determines the core index of cardiorespiratory fitness, such as the slope of oxygen pulse and oxygen uptake efficiency.These indexes can be used as an important criterion for predicting and guiding rehabilitation exercise in patients with coronary heart disease.
Collapse
Affiliation(s)
- Y P Wang
- Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; NHFPC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides; Key Laboratory of Molecular Cardiovascular Science, Beijing 100191, China
| | | | | | | | | | | | | |
Collapse
|
208
|
Zhao W, Peng Y, Mills GB, Peng G. Abstract PD8-11: APOBEC3 contributes to mutational load in breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-pd8-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Breast cancer results in large part from the accumulation of multiple mutations in premalignant cells, which provide a molecular basis for genetic diversity. This genetic diversity in premalignant cells allows selection for increased proliferation and survival and ultimately leads to invasion, metastasis, and therapeutic resistance. Recent genome-wide sequencing data showed that APOBEC3B (A3B) contributes to mutational load in breast cancer. A3B, a DNA cytosine deaminase, is overexpressed in more than 50% of breast tumors and more than 75% of breast cancer cell lines. Its overexpression and aberrant activation lead to unexpected clusters of mutations in the majority of breast cancers. This phenomenon of clustered mutations, termed kataegis (shower in Greek) forms a unique mutation signature in breast cancer. On the basis of the finding that A3B is a key molecular determinant of the mutator phenotype in breast cancer, the goal of our research is to utilize informatics tools to systematically characterize genetic alterations of APOBEC3 family proteins in breast cancer genomic data and define the molecular impact of altered APOBEC3 family proteins on mutability and anti-tumor immunity.
Our data showed that the mutation rate and copy number amplification/deletion of APOBEC3 genes are low. The levels of APOBEC3A (A3A) and A3B are highly correlated and are highest in Basal subtype and lowest in Luminal A tumors, in concordance with the proliferation of subtypes. Additionally, A3A and A3B are significantly correlated with total mutational load as well as with TP53 mutation, and with somatic copy number alterations (SCNA), especially focal SCNA. Among APOBEC3 genes, A3B is significantly associated DNA replication, DNA damage repair, cell cycle and proteasome signatures, and shows predictive and prognostic capacity in ER-positive patients. Interestingly, A3G expression is strongly associated with immune response signature genes in all breast tumors. Consequently, A3G is highly associated with tumor-infiltrating lymphocytes in breast and several other disease types.
In summary, our data demonstrate distinct expression pattern of APOBEC3 genes in different breast cancer subpopulations. Overexpression of different APOBEC3 family members leads to distinct molecular consequences. These data provide new molecular insights into pathophysiological functions of APOBEC3 genes in breast cancer and provide therapeutic opportunities for the breast cancer patients whose tumors have altered APOBEC3 expression levels and potentially are driven by APOBEC3 genes. Importantly, APOBEC3G is associated with evidence of immune activation that may signal responsiveness to immune checkpoint inhibitors.
Citation Format: Zhao W, Peng Y, Mills GB, Peng G. APOBEC3 contributes to mutational load in breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr PD8-11.
Collapse
Affiliation(s)
- W Zhao
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Y Peng
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - GB Mills
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - G Peng
- The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
209
|
Hu MN, Zhang Y, Zhao W. [Analysis of 649 cases of stillbirth in third trimester]. Zhonghua Fu Chan Ke Za Zhi 2017; 52:822-827. [PMID: 29325266 DOI: 10.3760/cma.j.issn.0529-567x.2017.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the risk factors of stillbirth in third trimester. Methods: Clinical data of 649 cases of stillbirth in third trimester were analyzed retrospectively in 22 hospitals of Haidian district from October 2011 to September 2016, including the incidence, the maternal profile, the perinatal care during pregnancy and the causes of stillbirth. Results: (1) The incidence of stillbirth in third trimester in Haidian district from October 2011 to September 2016 was 0.293%(649/221 845). While the incidence in floating pregnant women (0.349%, 342/97 939) was higher than that in the residence (0.248%, 307/123 906), with statistically significant difference (χ(2)=19.178, P<0.01). The incidence of stillbirth in multiple pregnancy(0.201%, 89/4 264) was higher than that in singleton pregnancy (0.257%, 560/217 581), with statistically significant difference(χ(2)=4.690, P<0.01). There was no statistically significant difference in the incidence of stillbirth between male (0.300%, 347/115 632) and female fetuses (0.284%, 302/106 205; χ(2)=0.467, P>0.05).(2)Among the 649 cases, the floating population accounted for the majority of those who never had prenatal visit (84.0%, 21/25), or less than 5 visits (80.7%, 125/155), or the first visit was beyond 13 gestational weeks(66.0%, 165/649). The causes of stillbirth in order were fetal factors (30.7%, 199/649), maternal factors(28.0%, 182/649), umbilical cord factors (20.0%, 130/649), unexplained factors (17.6%, 114/649) and placental factors (3.7%, 24/649). Birth defects, pregnancy hypertensive disorders, umbilical cord entanglement or torsion were the most important factors, accounting for 22.8%(148/649), 17.4%(113/649), 17.3%(112/649), respectively. Conclusions: The floating pregnant women are key population of stillbirth in third trimester. Maternal care and education should be strengthened in this population. The prevention of birth defect, better prenatal care in women with complications, and close monitor during labor are the key measures to reduce the incidence of stillbirth in third trimester.
Collapse
Affiliation(s)
- M N Hu
- Department of Health Care, Haidian Maternal and Child Health Hospital, Beijing 100080, China
| | | | | |
Collapse
|
210
|
Feng B, Shang J, Wu SH, Chen H, Han Y, Li YQ, Zhang DZ, Zhao LF, Wei SF, Mao Q, Yin CB, Han T, Wang MR, Chen SJ, Li J, Xie Q, Zhen Z, Gao ZL, Zhang YX, Gong GZ, Yang DL, Pan C, Sheng JF, Tang H, Ning Q, Shi GF, Niu JQ, Luo GH, Sun YT, You H, Wang GQ, Zhang LL, Peng J, Zhang Q, Liu JJ, Chen CW, Chen XY, Zhao W, Wang RH, Sun L, Wei L. [Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C]. Zhonghua Gan Zang Bing Za Zhi 2017; 25:187-194. [PMID: 28482405 DOI: 10.3760/cma.j.issn.1007-3418.2017.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To investigate the efficacy and safety of the new investigational drug pegylated interferon α-2b (Peg-IFN-α-2b) (Y shape, 40 kD) injection (180 µg/week) combined with ribavirin in the treatment of patients with genotype 1/6 chronic hepatitis C (CHC), with standard-dose Peg-IFN-α-2a combined with ribavirin as a positive control. Methods: A multicenter, randomized, open-label, and positive-controlled phase III clinical trial was performed. Eligible patients with genotype 1/6 CHC were screened out and randomly divided into Peg-IFN-α-2b(Y shape, 40kD) group and Peg-IFN-α-2a group at a ratio of 2:1. The patients in both groups were given oral ribavirin for 48 weeks in addition and then followed up for 24 weeks after drug withdrawal. Abbott Real Time HCV Genotype II was used to determine HCV genotype, and Cobas TaqMan quantitative real-time PCR was used to measure HCV RNA level at 0, 4, 12, 24, 48, and 72 weeks. Adverse events were recorded in detail. The primary efficacy endpoint was sustained virological response (SVR), and a non-inferiority test was also performed. Results: A total of 561 patients with genotype 1/6 CHC were enrolled, among whom 529 received treatment; 90.9% of these patients had genotype 1 CHC. The data of the full analysis set showed that SVR rate was 69.80% (95% CI 65.00%-74.60%) in the trial group and 74.16% (95% CI 67.73%-80.59%) in the control group (P = 0.297 0). The data of the per protocol set (PPS) showed that SVR rate was 80.63% (95% CI 76.04%-85.23%) in the trial group and 81.33% (95% CI 75.10%-87.57%) in the control group (P = 0.849 8), and the 95% CI of rate difference conformed to the non-inferiority standard. The analysis of the PPS population showed that of all subjects, 47.9% achieved rapid virologic response, with a positive predictive value of 93.8%. The incidence rate of adverse events was 96.30% in the trial group and 94.94% in the control group, and the incidence rate of serious adverse events was 5.13% in the trail group and 5.06% in the control group. Conclusion: In the regimen of Peg-IFN-α combined with ribavirin for the treatment of genotype 1/6 CHC, the new investigational drug Peg-IFN-α-2b(Y shape, 40 kD) has comparable clinical effect and safety to the control drug Peg-IFN-α-2a.
Collapse
Affiliation(s)
- B Feng
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing 100044, China
| | - J Shang
- Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - S H Wu
- Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - H Chen
- Department of Infectious Diseases, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000, China
| | - Y Han
- Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Y Q Li
- Department of Infectious Diseases, 302 Military Hospital, Beijing 100039, China
| | - D Z Zhang
- Department of Infectious Diseases, Institute for Viral Hepatitis, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - L F Zhao
- Department of Infectious Diseases, The First Affiliated Hospital of Shanxi University, Taiyuan 030001, China
| | - S F Wei
- Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
| | - Q Mao
- Department of Infectious Disease, Southeast Hospital, Third Military Medical University, Chongqing 400038, China
| | - C B Yin
- Department of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou 510060, China
| | - T Han
- Department of Hepatology, Tianjin Third Central Hospital, Tianjin Medical University, Tianjin 300170, China
| | - M R Wang
- Institute of Liver Disease, Nanjing 81 Hospital, Nanjing 210002, China
| | - S J Chen
- Department of Hepatology, Jinan Infectious Disease Hospital, Jinan 250021, China
| | - J Li
- Department of Infectious Diseases, Jiangsu Provincial People's Hospital, Nanjing 210029, China
| | - Q Xie
- Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - Z Zhen
- Department of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China
| | - Z L Gao
- Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
| | - Y X Zhang
- Department of Infectious Diseases, The First Affiliated Hospital of Xinjiang Medical University, Wulumuqi 830054, China
| | - G Z Gong
- Department of Infectious Diseases, The Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - D L Yang
- Department of Infectious Disease, Institute of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - C Pan
- Department of Hepatology, Fuzhou Infectious Disease Hospital, Fuzhou, 350025, China
| | - J F Sheng
- The First Affiliated Hospital of Zhengjiang University, Hangzhou 310003, China
| | - H Tang
- Department of Infectious Diseases, Sichuan University West China Hospital, Chengdu 610041, China
| | - Q Ning
- Department of Infectious Disease, Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - G F Shi
- Department of Infectious Diseases, Huashan Hospital, Shanghai 200040, China
| | - J Q Niu
- Department of Infectious Diseases, The First Affiliated Hospital of Jilin University, Changchun 130062, China
| | - G H Luo
- Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical Universtiy, Nanning 530021, China
| | - Y T Sun
- Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China
| | - H You
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - G Q Wang
- Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China
| | - L L Zhang
- Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang 360102, China
| | - J Peng
- Department of Infectious Diseases, Nangfang Hospital, Southern Medical University, Guangzhou 510510, China
| | - Q Zhang
- Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
| | - J J Liu
- Department of Infectious Diseases, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China
| | - C W Chen
- Nanjing Military Command Liver Disease Research Center, Shanghai 200000, China
| | - X Y Chen
- Hepatology Department, Youan Hospital, Capital Medical University, Beijing 100069, China
| | - W Zhao
- Department of Hepatology, The Second Affiliated Hospital of the Southeast University, Nanjing 210003, China
| | - R H Wang
- Xiamen Amoytop Biotech Co., Ltd, Xiamen, 361022, China
| | - L Sun
- Xiamen Amoytop Biotech Co., Ltd, Xiamen, 361022, China
| | - L Wei
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing 100044, China
| |
Collapse
|
211
|
Li Y, Zhao M, Guo C, Chu H, Li W, Chen X, Wang X, Li Y, Jia Y, Koussatidjoa S, Zhu F, Wang J, Wang X, Wang Q, Zhao W, Shi Y, Chen W, Zhang L. Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation. Oncogene 2017; 37:1095-1106. [PMID: 29106392 DOI: 10.1038/onc.2017.405] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2016] [Revised: 06/24/2017] [Accepted: 09/24/2017] [Indexed: 12/18/2022]
Abstract
IL-37, a newly found anti-inflammatory cytokine of the IL-1 family, has both extracellular and intracellular functions. Accumulating evidences indicate that it is also involved in tumor progression. However, the mechanism and its intracellular target are unclear. In this study, clinical data from 84 patients showed that loss or reduced expression of IL-37 in lung adenocarcinoma tissues was significantly associated with tumor metastasis. We further provided evidence that IL-37 inhibited effectively tumor metastasis in vitro and in vivo. Moreover, we uncovered a novel mechanism by which IL-37 suppressed tumor cell migration via its intracellular mature form (amino acids 46-218). Intracellular mature form of IL-37, but not its extracellular form, markedly inhibited migration of multiple kinds of tumor cells through inhibiting Rac1 activation. Mechanistically, intracellular mature IL-37 directly bound to the CAAX motif in the C-terminal hypervariable region of Rac1, and then inhibited Rac1 membrane translocation and subsequent downstream signaling. Our research identifies intracellular mature IL-37 as a novel endogenous inhibitor of Rac1. Given the crucial roles of Rac1 in tumor angiogenesis and metastasis, intracellular mature IL-37 might serve as a potential strategy for the control of Rac1 activity and tumor progression.
Collapse
Affiliation(s)
- Y Li
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - M Zhao
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - C Guo
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - H Chu
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - W Li
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - X Chen
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - X Wang
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - Y Li
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - Y Jia
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - S Koussatidjoa
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - F Zhu
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - J Wang
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - X Wang
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - Q Wang
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - W Zhao
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - Y Shi
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| | - W Chen
- Mucosal Immunology Section, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Bethesda, MD, USA
| | - L Zhang
- Department of Immunology and Key Laboratory of Infection and Immunity of Shandong Province, Shandong University School of Basic Medical Sciences, Jinan, China
| |
Collapse
|
212
|
Moreau P, Bucalossi J, Missirlian M, Samaille F, Courtois X, Gil C, Lotte P, Meyer O, Nardon E, Nouailletas R, Ravenel N, Travere J, Alarcon T, Antusch S, Aumeunier M, Barjat P, Belsare S, Bernard J, Bhandarkar M, Bottereau C, Bourdelle C, Brémond S, Camenen Y, Chaudhari V, Chavda C, Chernyshova M, Clairet F, Colnel J, Czarski T, Choi M, Colledani G, Corre Y, Daniel R, Davis D, Dejarnac R, Devynck P, Dhongde J, Douai D, Elbeze D, Escarguel A, Fenzi C, Figacz W, Guangwu Z, Giacalone J, Guirlet R, Gunn J, Hacquin S, Hao X, Harris J, Hoang G, Houry M, Imbeaux F, Jablonski S, Jardin A, Joshi H, Kasprowicz G, Klepper C, Kowalska-Strzeciwilk E, Kubkowska M, Kumar A, Kumar V, Kumari P, Laqua H, Le-Luyer A, Lee W, Lewerentz M, Lyu B, Malard P, Manenc L, Mansuri I, Marandet Y, Masand H, Mazon D, Molina D, Moureau G, Nam Y, Park H, Pascal J, Patel K, Patel M, Pozniak K, Radloff D, Ranjan S, Rapson C, Raupp G, Rieth M, Sabot R, Santraine B, Sestac D, Sharma M, Shen J, Signoret J, Soni J, Spring A, Spuig P, Sugandhi R, Treuterrer W, Tsitrone E, Varshney S, Vartanian S, Volpe D, Wang F, Werner A, Yun G, Zabolotny W, Zhao W. Measurements and controls implementation for WEST. Fusion Engineering and Design 2017. [DOI: 10.1016/j.fusengdes.2017.01.046] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
213
|
Gu X, Liu M, Cheng M, Zhang Z, Zhao W, Cheng W. Systematic inflammatory response markers (SIRs) factors associated with pain prevalence and other characteristics in advanced cancer patients. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
214
|
Kasliwal MM, Nakar E, Singer LP, Kaplan DL, Cook DO, Van Sistine A, Lau RM, Fremling C, Gottlieb O, Jencson JE, Adams SM, Feindt U, Hotokezaka K, Ghosh S, Perley DA, Yu PC, Piran T, Allison JR, Anupama GC, Balasubramanian A, Bannister KW, Bally J, Barnes J, Barway S, Bellm E, Bhalerao V, Bhattacharya D, Blagorodnova N, Bloom JS, Brady PR, Cannella C, Chatterjee D, Cenko SB, Cobb BE, Copperwheat C, Corsi A, De K, Dobie D, Emery SWK, Evans PA, Fox OD, Frail DA, Frohmaier C, Goobar A, Hallinan G, Harrison F, Helou G, Hinderer T, Ho AYQ, Horesh A, Ip WH, Itoh R, Kasen D, Kim H, Kuin NPM, Kupfer T, Lynch C, Madsen K, Mazzali PA, Miller AA, Mooley K, Murphy T, Ngeow CC, Nichols D, Nissanke S, Nugent P, Ofek EO, Qi H, Quimby RM, Rosswog S, Rusu F, Sadler EM, Schmidt P, Sollerman J, Steele I, Williamson AR, Xu Y, Yan L, Yatsu Y, Zhang C, Zhao W. Illuminating gravitational waves: A concordant picture of photons from a neutron star merger. Science 2017; 358:1559-1565. [PMID: 29038373 DOI: 10.1126/science.aap9455] [Citation(s) in RCA: 441] [Impact Index Per Article: 63.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Accepted: 10/05/2017] [Indexed: 11/02/2022]
Abstract
Merging neutron stars offer an excellent laboratory for simultaneously studying strong-field gravity and matter in extreme environments. We establish the physical association of an electromagnetic counterpart (EM170817) with gravitational waves (GW170817) detected from merging neutron stars. By synthesizing a panchromatic data set, we demonstrate that merging neutron stars are a long-sought production site forging heavy elements by r-process nucleosynthesis. The weak gamma rays seen in EM170817 are dissimilar to classical short gamma-ray bursts with ultrarelativistic jets. Instead, we suggest that breakout of a wide-angle, mildly relativistic cocoon engulfing the jet explains the low-luminosity gamma rays, the high-luminosity ultraviolet-optical-infrared, and the delayed radio and x-ray emission. We posit that all neutron star mergers may lead to a wide-angle cocoon breakout, sometimes accompanied by a successful jet and sometimes by a choked jet.
Collapse
Affiliation(s)
- M M Kasliwal
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.
| | - E Nakar
- The Raymond and Beverly Sackler School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
| | - L P Singer
- Astroparticle Physics Laboratory, NASA Goddard Space Flight Center, Mail Code 661, Greenbelt, MD 20771, USA.,Joint Space-Science Institute, University of Maryland, College Park, MD 20742, USA
| | - D L Kaplan
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - D O Cook
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - A Van Sistine
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - R M Lau
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - C Fremling
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - O Gottlieb
- The Raymond and Beverly Sackler School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
| | - J E Jencson
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - S M Adams
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - U Feindt
- The Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - K Hotokezaka
- Center for Computational Astrophysics, Simons Foundation, Flatiron Institute, 162 5th Avenue, New York, NY 10010, USA.,Department of Astrophysical Sciences, Princeton University, Peyton Hall, Princeton, NJ 08544, USA
| | - S Ghosh
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - D A Perley
- Astrophysics Research Institute, Liverpool John Moores University, IC2, Liverpool Science Park, 146 Browlow Hill, Liverpool L3 5RF, UK
| | - P-C Yu
- Graduate Institute of Astronomy, National Central University, No. 300, Zhongda Road, Zhongli District, Taoyuan City 32001, Taiwan
| | - T Piran
- Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - J R Allison
- Sydney Institute for Astronomy, School of Physics A28, The University of Sydney, New South Wales 2006, Australia.,Australian Research Council Centre of Excellence for All-sky Astrophysics in 3 Dimensions, Australia
| | - G C Anupama
- Indian Institute of Astrophysics, II Block Koramangala, Bangalore 560034, India
| | - A Balasubramanian
- Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pashan, Pune 411008, India
| | - K W Bannister
- Australia Telescope National Facility, Astronomy and Space Science, Commonwealth Scientific and Industrial Research Organisation, Post Office Box 76, Epping, New South Wales 1710, Australia
| | - J Bally
- Department of Astrophysical and Planetary Sciences, University of Colorado, Boulder, CO 80305, USA
| | - J Barnes
- Columbia Astrophysics Laboratory, Columbia University, New York, NY 10027, USA
| | - S Barway
- South African Astronomical Observatory, Post Office Box 9, Observatory, Cape Town 7935, South Africa
| | - E Bellm
- Department of Astronomy, University of Washington, Seattle, WA 98195, USA
| | - V Bhalerao
- Department of Physics, Indian Institute of Technology Bombay, Mumbai 400076, India
| | - D Bhattacharya
- Inter-University Centre for Astronomy and Astrophysics, Post Office Bag 4, Ganeshkhind, Pune 411007, India
| | - N Blagorodnova
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - J S Bloom
- Department of Astronomy, University of California, Berkeley, CA 94720-3411, USA.,Lawrence Berkeley National Laboratory, 1 Cyclotron Road, MS 50B-4206, Berkeley, CA 94720, USA
| | - P R Brady
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - C Cannella
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - D Chatterjee
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - S B Cenko
- Astroparticle Physics Laboratory, NASA Goddard Space Flight Center, Mail Code 661, Greenbelt, MD 20771, USA.,Joint Space-Science Institute, University of Maryland, College Park, MD 20742, USA
| | - B E Cobb
- Department of Physics, George Washington University, Washington, DC 20052, USA
| | - C Copperwheat
- Astrophysics Research Institute, Liverpool John Moores University, IC2, Liverpool Science Park, 146 Browlow Hill, Liverpool L3 5RF, UK
| | - A Corsi
- Department of Physics and Astronomy, Texas Tech University, Box 41051, Lubbock, TX 79409-1051, USA
| | - K De
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - D Dobie
- Sydney Institute for Astronomy, School of Physics A28, The University of Sydney, New South Wales 2006, Australia.,Australian Research Council Centre of Excellence for All-sky Astrophysics, Australia.,Australia Telescope National Facility, Astronomy and Space Science, Commonwealth Scientific and Industrial Research Organisation, Post Office Box 76, Epping, New South Wales 1710, Australia
| | - S W K Emery
- University College London, Mullard Space Science Laboratory, Holmbury St. Mary, Dorking RH5 6NT, UK
| | - P A Evans
- X-ray and Observational Astronomy Research Group, Leicester Institute for Space and Earth Observation, Department of Physics and Astronomy, University of Leicester, University Road, Leicester, LE1 7RH, UK
| | - O D Fox
- Space Telescope Science Institute, 3700 San Martin Drive, Baltimore, MD 21218, USA
| | - D A Frail
- National Radio Astronomy Observatory, Socorro, NM 87825, USA
| | - C Frohmaier
- Department of Physics and Astronomy, University of Southampton, Southampton, Hampshire SO17 1BJ, UK.,Institute of Cosmology and Gravitation, Dennis Sciama Building, University of Portsmouth, Burnaby Road, Portsmouth PO1 3FX, UK
| | - A Goobar
- The Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - G Hallinan
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - F Harrison
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - G Helou
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, CA 91125, USA
| | - T Hinderer
- Institute of Mathematics, Astrophysics and Particle Physics, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, Netherlands
| | - A Y Q Ho
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - A Horesh
- Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - W-H Ip
- Department of Astrophysical Sciences, Princeton University, Peyton Hall, Princeton, NJ 08544, USA
| | - R Itoh
- Department of Physics, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8551, Japan
| | - D Kasen
- Department of Astronomy, University of California, Berkeley, CA 94720-3411, USA.,Department of Physics, University of California, Berkeley, CA 94720, USA
| | - H Kim
- Gemini Observatory, Casilla 603, La Serena, Chile
| | - N P M Kuin
- University College London, Mullard Space Science Laboratory, Holmbury St. Mary, Dorking RH5 6NT, UK
| | - T Kupfer
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - C Lynch
- Sydney Institute for Astronomy, School of Physics A28, The University of Sydney, New South Wales 2006, Australia.,Australian Research Council Centre of Excellence for All-sky Astrophysics, Australia
| | - K Madsen
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - P A Mazzali
- Astrophysics Research Institute, Liverpool John Moores University, IC2, Liverpool Science Park, 146 Browlow Hill, Liverpool L3 5RF, UK.,Max-Planck Institute for Astrophysics, Garching, Germany
| | - A A Miller
- Center for Interdisciplinary Exploration and Research in Astrophysics and Department of Physics and Astronomy, Northwestern University, Evanston, IL 60208, USA.,The Adler Planetarium, Chicago, IL 60605, USA
| | - K Mooley
- Astrophysics, Department of Physics, University of Oxford, Keble Road, Oxford OX1 3RH, UK
| | - T Murphy
- Sydney Institute for Astronomy, School of Physics A28, The University of Sydney, New South Wales 2006, Australia.,Australian Research Council Centre of Excellence for All-sky Astrophysics, Australia
| | - C-C Ngeow
- Graduate Institute of Astronomy, National Central University, No. 300, Zhongda Road, Zhongli District, Taoyuan City 32001, Taiwan
| | - D Nichols
- Institute of Mathematics, Astrophysics and Particle Physics, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, Netherlands
| | - S Nissanke
- Institute of Mathematics, Astrophysics and Particle Physics, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, Netherlands
| | - P Nugent
- Department of Astronomy, University of California, Berkeley, CA 94720-3411, USA.,Lawrence Berkeley National Laboratory, 1 Cyclotron Road, MS 50B-4206, Berkeley, CA 94720, USA
| | - E O Ofek
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - H Qi
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - R M Quimby
- Department of Astronomy, San Diego State University, San Diego, CA 92182, USA.,Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - S Rosswog
- The Oskar Klein Centre, Department of Astronomy, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Rusu
- School of Engineering (EECS), University of California, Merced, CA 95343, USA
| | - E M Sadler
- Sydney Institute for Astronomy, School of Physics A28, The University of Sydney, New South Wales 2006, Australia.,Australian Research Council Centre of Excellence for All-sky Astrophysics, Australia
| | - P Schmidt
- Institute of Mathematics, Astrophysics and Particle Physics, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, Netherlands
| | - J Sollerman
- The Oskar Klein Centre, Department of Astronomy, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - I Steele
- Astrophysics Research Institute, Liverpool John Moores University, IC2, Liverpool Science Park, 146 Browlow Hill, Liverpool L3 5RF, UK
| | - A R Williamson
- Institute of Mathematics, Astrophysics and Particle Physics, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, Netherlands
| | - Y Xu
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
| | - L Yan
- Division of Physics, Math and Astronomy, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.,Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, CA 91125, USA
| | - Y Yatsu
- Department of Physics, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8551, Japan
| | - C Zhang
- Department of Physics, University of Wisconsin, Milwaukee, WI 53201, USA
| | - W Zhao
- School of Engineering (EECS), University of California, Merced, CA 95343, USA
| |
Collapse
|
215
|
Guo P, Ma X, Zhao W, Huai W, Li T, Qiu Y, Zhang Y, Han L. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1–TSC2 complex. Oncogene 2017; 37:478-488. [DOI: 10.1038/onc.2017.349] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Revised: 08/16/2017] [Accepted: 08/21/2017] [Indexed: 12/20/2022]
|
216
|
Zhao W, Han B, Vernekohl D, Liu H, Min J, Xing L. Material Decomposition Using Triple-Energy CT for Accurate Proton Therapy Dose Calculation. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.443] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
217
|
Zhao W, Li L, Zhu X. Radiosensitivity Effect and Regulatory Mechanisms of PARP-1 Inhibitors on Brca Mutant Breast Cancer. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
218
|
Lin Y, Xie HH, Zhao W, Wu M, Gu WY. [The 458th case: fever, cytopenia, abdominal pain, and multiple intestinal ulcerations with perforation]. Zhonghua Nei Ke Za Zhi 2017; 56:789-792. [PMID: 29036968 DOI: 10.3760/cma.j.issn.0578-1426.2017.10.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Trisomy 8 in myelodysplastic syndrome (MDS) plays an important role in concurrent intestinal Behçet's disease (BD) pathogenesis. Here, we reported a case of intestinal BD combined with MDS involving trisomy 8. A 48-year-old woman who has had a 20-year history of recurrent oral ulcer, perineal ulcer and iris, was diagnosed as MDS with trisomy 8 four years ago. She developed high fever and acute abdominal pain. Multiple ulcerative perforations in ileum and colon were found by endoscopy, meeting the criteria for intestinal BD. The patient was successfully treated with immunomodulatory drugs.
Collapse
Affiliation(s)
| | | | | | | | - W Y Gu
- Department of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, Jiangsu Province, China
| |
Collapse
|
219
|
Wang H, Wang Y, Lu J, Cui Q, Zhao W. Infective endocarditis presenting as an acute ischemic stroke: A case report and analysis of the case series. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
220
|
Zhao W, Zhu X, Li L. The Clinical Characteristics of Secondary Primary Tumors in Patients With Nasopharyngeal Carcinoma after Intensity-Modulated Radiation Therapy: A Retrospective Analysis. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
221
|
Hu HQ, Zhang J, Zhao W, Tian T, Huang AQ, Wang LL. [The occurrence and determinants of anxiety and depression symptoms in women of six counties/ districts in China during pregnancy]. Zhonghua Yu Fang Yi Xue Za Zhi 2017; 51:47-52. [PMID: 28056270 DOI: 10.3760/cma.j.issn.0253-9624.2017.01.010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To estimate the prevalence of anxiety and depression symptoms during pregnancy among women from six districts of China and to explore the determinants of anxiety and depression during pregnancy. Methods: A cross-sectional study of maternal health status was conducted using the probability proportionate to size sampling method among pregnant women from six counties/districts in six provinces of China (Hebei, Liaoning, Fujian, Hunan, Sichuan and Yunnan). A questionnaire was completed by each of the women included in the study from August to December 2014. Women were recruited from three medical and health institutions with the most obstetrics patients in each district. A total of 4 210 pregnant women were included in the investigation. The hospital anxiety and depression (HAD) scale was applied to measure the symptoms of anxiety and depression in the pregnant women. Trend chi square test was used to assess the differences of anxiety and depression symptom among three trimesters. The multivariate logistic regression model was used to investigate potential contributory factors. Results: The detection rates for anxiety symptoms and depression symptoms during pregnancy were 8.5% (357/4 210) and 12.5% (525/4 210), respectively. The prevalence of anxiety symptoms during the first, second and third trimesters were 7.9% (110/1 392), 8.8% (124/1 413) and 8.8% (123/1 405), respectively (χ2trend=0.89, P= 0.419). The prevalence of depression symptoms during the first, second and third trimesters were 14.0% (195/1 392), 12.6% (178/1 413) and 10.8% (152/1 405), respectively (χ2trend=6.52, P=0.011). Multivariate logistic regression analysis showed an increased risk of anxiety and depression in women with an educational background of middle school rather than a college degree (OR=1.94, 95% CI: 1.44-2.63; OR=3.80, 95% CI: 2.45- 5.91). Furthermore, compared with planned pregnancies, women with unplanned pregnancies had a higher risk of anxiety and depression (OR=1.33, 95% CI: 1.06- 1.66; OR=1.35, 95% CI: 1.07- 1.71). Pregnant women who felt they lived in crowded residential conditions were at an increased risk of anxiety compared with those living in spacious residential environments (OR=1.82, 95% CI: 1.15- 2.87). Pregnant women with a household income of less than 10 000 yuan were at a higher risk of depression than living in a household with an income of ≥100 000 yuan (OR=1.91, 95% CI: 1.05-3.49). Similarly, multiparous women (≥2) were at higher risk of depression compared with nulliparous women (OR=1.88, 95% CI: 1.04- 3.41). Conclusion: The prevalence of anxiety and depression symptoms during pregnancy appears to be associated with several demographic factors, along with a women's obstetrical history. Lower educational background, unplanned pregnancy, the feeling of living under crowded residential conditions were all found to be risk factors for anxiety during pregnancy. Similarly, lower educational background, unplanned pregnancy, a lower household income (<10 000) and a greater number of previous deliveries were all risk factors for depression during pregnancy.
Collapse
Affiliation(s)
- H Q Hu
- Maternal and Children's Health Surveillance Department, National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - J Zhang
- Institute of Reproductive and Child Health, Peking University/Key Laboratory of Reproductive Health, National Health and Family Planning Commission of the People's Republic of China, Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | | | | | | | | |
Collapse
|
222
|
Yang P, Jing HM, Zhao W, Hu K, Dong F, Li QH, Wan W, Tian L, Wang JJ, Ke XY. [Analysis of survival and treatment outcome of young patients with high-risk diffuse large B cell lymphoma]. Zhonghua Yi Xue Za Zhi 2017; 97:2485-2490. [PMID: 28835053 DOI: 10.3760/cma.j.issn.0376-2491.2017.32.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze clinical feature and treatment outcome of young patients with high-risk diffuse large B cell lymphoma. Methods: A total of 122 young patients with high-risk diffuse large B cell lymphoma who were treated in Third Hospital of Peking University during the period from January 2000 to April 2015 were retrospectively analyzed, and the clinical features, laboratory data were included in Kaplan-Meier and prognostic analysis. Results: In our center, the incidence of young high-risk DLBCL was 27.1% in all DLBCL patients, median age was 44.0 years, 99.2% patients belong to Ⅲ and Ⅳstage, 50% patients had more than two extranodal organs involvement, and the higher proliferation index(Ki-67≥80%) was present in 63.1% of patients, Immunohistochemistry showed that 36.7% patients in 30 cases were double-expressed DLBCL. The overall response rate(ORR) for the whole group was 79.4%, the complete response rate was 39.7% , the 3, 5-year progression free survival rate was 59.8% and 57.0%, the 3, 5-year overall survival rate was 63.5% and 57.8%, respectively. 44.3% patients were refractory-relapsed DLBCL. Rituximab can improve the survival of patients and 3-year overall survival rate was 75.2% vs 46.1%(P=0.001). High-dose chemotherapy was superior to CHOP regimen which 3-year overall survival rate was 84.6% vs 54.1%(P=0.006). Compared with chemotherapy group , auto-hematopoietic stem cell transplantation can improve prognosis of patients and 3-year overall survival rate was 93.4% vs 48.3%(P<0.001). The level of Ki-67, B symptom, ECOG score, the level of LDH, WBC and albumin, ESR level, anemia, rituximab therapy, initial regimens, ASCT, initial treatment outcome and refractory-relapsed were predictive of overall survival. Multivariate analysis indicated that albumin level(RR=5.462, P=0.019), initial treatment outcome(RR=34.863, P<0.001) and refractory-relapsed (RR=24.374, P<0.001)were independent prognostic risk factors. Conclusions: Young patients with high-risk DLBCL were highly aggressive in clinical and pathological features . Rituximab and high-dose regimens can improve the survival of patients.
Collapse
Affiliation(s)
- P Yang
- Department of Hematology, Third Hospital of Peking University, Beijing 100191, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
223
|
Nolan K, Tippimanchai D, Verzosa G, Zhao W, Li H, Phillip S, Malkoski S. Reduced TGFBR2 Expression in NSCLC Drives IL-17A Dependent Inflammation via γδT Cells. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.06.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
224
|
Zhao W, Geng P, Lei L, Awad H, Li Y, Wei X, Zhu Z, Cheng J. HOW TO SCREEN POST-MENOPAUSAL FEMALES WITH CERVICAL CARCINOMA? A DISCUSSION ON THE METHODS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.3274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- W. Zhao
- Shanghai East hospital, Shanghai, China
| | - P. Geng
- Shanghai East hospital, Shanghai, China
| | - L. Lei
- Shanghai East hospital, Shanghai, China
| | - H. Awad
- Shanghai East hospital, Shanghai, China
| | - Y. Li
- Shanghai East hospital, Shanghai, China
| | - X. Wei
- Shanghai East hospital, Shanghai, China
| | - Z. Zhu
- Shanghai East hospital, Shanghai, China
| | - J. Cheng
- Shanghai East hospital, Shanghai, China
| |
Collapse
|
225
|
Zhao W, Ukawa S, Okada E, Wakai K, Kawamura T, Ando M, Tamakoshi A. THE ASSOCIATION OF DIETARY PATTERN WITH OVERALL MORTALITY, AND OTHER LIFESTYLES IN JAPANESE ELDERLY. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- W. Zhao
- Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan,
| | - S. Ukawa
- Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan,
| | - E. Okada
- Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan,
| | - K. Wakai
- Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan,
| | - T. Kawamura
- Kyoto University Health Service, Kyoto, Japan,
| | - M. Ando
- Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Aichi, Japan
| | - A. Tamakoshi
- Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan,
| |
Collapse
|
226
|
Ma JL, Yue Q, Wang Q, Li J, Wong HT, Lin ST, Liu SK, Wang L, Jiang H, Yang LT, Jia LP, Chen JH, Zhao W. Study of inactive layer uniformity and charge collection efficiency of a p-type point-contact germanium detector. Appl Radiat Isot 2017; 127:130-136. [PMID: 28586704 DOI: 10.1016/j.apradiso.2017.05.023] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Revised: 05/14/2017] [Accepted: 05/28/2017] [Indexed: 11/24/2022]
Abstract
The characteristics of the surface inactive layer of a 1-kg-mass p-type point-contact germanium detector were studied. The thickness of the inactive layer and its uniformity on the top and lateral surfaces were measured. A charge collection efficiency function was developed according to the Monte Carlo simulation to describe the charge collection capacity along the depth within this inactive layer. In the energy range below 18keV, the surface, bulk, and total spectra of 57Co, 133Ba, 137Cs, and 60Co from simulations based on the charge collection efficiency function were well consistent with those from experiments.
Collapse
Affiliation(s)
- J L Ma
- Department of Physics, Tsinghua University, Beijing 100084, China; Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - Q Yue
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China.
| | - Q Wang
- Department of Physics, Tsinghua University, Beijing 100084, China; Center for High Energy Physics, Tsinghua University, Beijing 100084, China; Collaborative Innovation Center of Quantum Matter, Beijing 100084, China
| | - J Li
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - H T Wong
- Institute of Physics, Academia Sinica, Taipei 11529, Taiwan
| | - S T Lin
- College of Physical Science and Technology, Sichuan University, Chengdu 610064, China
| | - S K Liu
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - L Wang
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - H Jiang
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - L T Yang
- Department of Physics, Tsinghua University, Beijing 100084, China; Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - L P Jia
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - J H Chen
- Institute of Physics, Academia Sinica, Taipei 11529, Taiwan
| | - W Zhao
- Key Laboratory of Particle and Radiation Imaging (Ministry of Education) and Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| |
Collapse
|
227
|
Han GR, Jiang HX, Wang CM, Ding Y, Wang GJ, Yue X, Zhou L, Zhao W. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy. J Viral Hepat 2017; 24:514-521. [PMID: 28039902 DOI: 10.1111/jvh.12670] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2016] [Accepted: 12/22/2016] [Indexed: 01/31/2023]
Abstract
Telbivudine, an FDA pregnancy category B drug, has been found to reduce hepatitis B virus (HBV) perinatal transmission with no safety concerns in infants aged up to 1 year. This study evaluated the long-term efficacy and safety of telbivudine in 214 infants born to 210 pregnant women with chronic hepatitis B infection who were treated with telbivudine during pregnancy (weeks 20-32 of gestation). The infants were followed for up to 5 years after birth. The efficacy endpoint was the rate of perinatal transmission, which was established by HBsAg and HBV DNA levels at 7 and 12 months. Safety endpoints included head circumference, weight, height, congenital abnormality and hospitalization rates. In addition, the Denver Developmental Screening Test was performed in 92 randomly selected infants. None of the 214 infants born to these women were infected with HBV, and all had effective serum hepatitis B surface antibody (HBsAb) levels. Compared with Chinese standard values, there were few differences in the infants' mean head circumference, weight, and height values. No birth defects were diagnosed, and the congenital abnormality rate was 0.934%. Serious adverse events requiring hospitalization occurred in 20 infants (9.35%). The qualified Denver Developmental Screening Test rate in 92 infants was 97.82%, which was comparable to a rate of 92% in normal Chinese children. Thus, treatment with telbivudine during the second or third trimesters of pregnancy safely blocked perinatal transmission of HBV. Infants born to telbivudine-treated mothers showed normal growth and development during long-term follow-up of up to 5 years.
Collapse
Affiliation(s)
- G-R Han
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| | - H-X Jiang
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| | - C-M Wang
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| | - Y Ding
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| | - G-J Wang
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| | - X Yue
- Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| | - L Zhou
- Department of Gynecology and Obstetrics, School of Medicine, Southeast University, Nanjing, China
| | - W Zhao
- Department of Infectious Diseases, The Second Affiliated Hospital of the Southeast University, Nanjing, China
| |
Collapse
|
228
|
Huang H, Xia Y, Gao Y, Wang X, Bai B, Cai Q, Zhao W, Yan Z, Li P, Lin T, Xia Z, Li Z, Jiang W. Newly diagnosed diffuse large B-cell lymphoma benefit from the addition of thymosin alpha 1 to R-CHOP: A propensity matched study from single institution. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_83] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- H. Huang
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - Y. Xia
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - Y. Gao
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - X. Wang
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - B. Bai
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - Q. Cai
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - W. Zhao
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - Z. Yan
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - P. Li
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - T. Lin
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - Z. Xia
- Department of Haematological Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - Z. Li
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| | - W. Jiang
- Department of Medical Oncology; Sun Yat-sen University Cancer Centre; Guangzhou China
| |
Collapse
|
229
|
Zhao W, Xu P, Fu D, Li J, Wang X, Hu J, Zhou J, Yu H, Zhao X, Su L, Chen Z, Zeng Q, Chen J, Fang M, Ma J, Liu T, Song Y, Yu K, Li Y, Qiu L, Chen X, Gu J, Yan J, Hou M, Xiong H. ANTHRACYCLINE DOSE INTENSIFICATION IN DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_48] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- W. Zhao
- State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China
| | - P. Xu
- State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China
| | - D. Fu
- State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China
| | - J. Li
- Department of Hematology; the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital; Nanjing China
| | - X. Wang
- Department of Hematology; Shandong Provincial Hospital Affiliated to Shandong University; Jinan China
| | - J. Hu
- Fujian Institute of Hematology; Fujian Medical University Union Hospital; Fuzhou China
| | - J. Zhou
- Department of Hematology; Tongji Medical College; Wuhan China
| | - H. Yu
- Department of research and development; Shanghai Righton Biotechnology Co. Ltd; Shanghai China
| | - X. Zhao
- State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China
| | - L. Su
- Department of Hematology; Shanxi Provincial Cancer Hospital; Taiyuan China
| | - Z. Chen
- Department of Hematology; the First People's Hospital of Foshan; Foshan China
| | - Q. Zeng
- Department of Hematology; the First Affiliated Hospital of Anhui Medical University; Hefei China
| | - J. Chen
- Department of Hematology, Southwestern Hospital; Third Military Medical University; Chongqing China
| | - M. Fang
- Department of Hematology; First Hospital of Dalian Medical University; Dalian China
| | - J. Ma
- Harbin Institute of Hematology and Oncology; Harbin First Hospital; Harbin China
| | - T. Liu
- Department of Hematology, Hematology Research Laboratory, West China Hospital; Sichuan University; Chengdu China
| | - Y. Song
- Department of Hematology; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital; Zhengzhou China
| | - K. Yu
- Department of Hematology; The First Affiliated Hospital of Wenzhou Medical University; Wenzhou China
| | - Y. Li
- Department of Hematology; The First Hospital of China Medical University; Shenyang China
| | - L. Qiu
- State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin China
| | - X. Chen
- Department of Hematology, Xijing Hospital; Fourth Military Medical University; Xi'an China
| | - J. Gu
- Institute of Hematology; Clinical Medical College of Yangzhou University, Subei People's Hospital of Jiangsu Province; Yangzhou China
| | - J. Yan
- Department of Hematology; Second Hospital of Dalian Medical University; Dalian China
| | - M. Hou
- Department of Hematology, Qilu Hospital; Shandong University; Jinan China
| | - H. Xiong
- Department of research and development; Shanghai Righton Biotechnology Co. Ltd; Shanghai China
| |
Collapse
|
230
|
Song Y, Li Y, Zheng S, Dai W, Shen X, Zhang Y, Zhao W, Chang G, Xu Q, Chen G. Effects of forage feeding versus grain feeding on the growth performance and meat quality of Yangzhou geese. Br Poult Sci 2017; 58:397-401. [DOI: 10.1080/00071668.2017.1307942] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Y. Song
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - Y. Li
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - S. Zheng
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - W. Dai
- Waterfowl Institute of Zhenjiang City, Dantu, China
| | - X. Shen
- Waterfowl Institute of Zhenjiang City, Dantu, China
| | - Y. Zhang
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - W. Zhao
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - G. Chang
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - Q. Xu
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| | - G. Chen
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, China
| |
Collapse
|
231
|
Jones D, Woyach JA, Zhao W, Caruthers S, Tu H, Coleman J, Byrd JC, Johnson AJ, Lozanski G. PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment. Leukemia 2017; 31:1645-1647. [PMID: 28366935 DOI: 10.1038/leu.2017.110] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- D Jones
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - J A Woyach
- Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - W Zhao
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - S Caruthers
- James Polaris Molecular Laboratory, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - H Tu
- James Polaris Molecular Laboratory, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - J Coleman
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - J C Byrd
- Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - A J Johnson
- Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - G Lozanski
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| |
Collapse
|
232
|
Yao L, Zhao H, Tang H, Xiong J, Zhao W, Liu L, Dong H, Zou F, Cai S. Blockade of β-catenin signaling attenuates toluene diisocyanate-induced experimental asthma. Allergy 2017; 72:579-589. [PMID: 27624805 DOI: 10.1111/all.13045] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/09/2016] [Indexed: 01/22/2023]
Abstract
BACKGROUND Aberrant activation of β-catenin signaling by both WNT-dependent and WNT-independent pathways has been demonstrated in asthmatic airways, which is thought to contribute critically in remodeling of the airways. Yet, the exact role of β-catenin in asthma is very poorly defined. As we have previously reported abnormal expression of β-catenin in a toluene diisocyanate (TDI)-induced asthma model, in this study, we evaluated the therapeutic efficacy of two small molecules XAV-939 and ICG-001 in TDI-asthmatic male BALB/c mice, which selectively block β-catenin-mediated transcription. METHODS Male BALB/c mice were sensitized and challenged with TDI to generate a chemically induced asthma model. Inhibitors of β-catenin, XAV-939, and ICG-001 were respectively given to the mice through intraperitoneally injection. RESULTS TDI exposure led to a significantly increased activity of β-catenin, which was then confirmed by a luciferase assay in 16HBE transfected with the TOPFlash reporter plasmid. Treatment with either XAV-939 or ICG-001 effectively inhibited activation of β-catenin and downregulated mRNA expression of β-catenin-targeted genes in TDI-asthmatic mice, paralleled by dramatically attenuated TDI-induced hyperresponsiveness and inflammation of the airway, alleviated airway goblet cell metaplasia and collagen deposition, decreased Th2 inflammation, as well as lower levels of TGFβ1, VEGF, HMGB1, and IL-1β. CONCLUSION The results showed that β-catenin is a principal mediator of TDI-induced asthma, proposing β-catenin as a promising therapeutic target in asthma.
Collapse
Affiliation(s)
- L. Yao
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - H. Zhao
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - H. Tang
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - J. Xiong
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - W. Zhao
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - L. Liu
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - H. Dong
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| | - F. Zou
- School of Public Health and Tropical Medicine; Southern Medical University; Guangzhou China
| | - S. Cai
- Department of Respiratory and Critical Care Medicine; Chronic Airways Diseases Laboratory; Nanfang Hospital; Southern Medical University; Guangzhou China
| |
Collapse
|
233
|
Lin Y, Zhao W, Shi Z, Gu H, Zhang X, Ji X, Zou X, Gong J, Yao W. Accumulation of antibiotics and heavy metals in meat duck deep litter and their role in persistence of antibiotic-resistant Escherichia coli in different flocks on one duck farm. Poult Sci 2017; 96:997-1006. [DOI: 10.3382/ps/pew368] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2016] [Accepted: 09/01/2016] [Indexed: 11/20/2022] Open
|
234
|
Wang S, Pan XF, Zhao W, Yan HF. [Determination of thiocyanate within human urine by ion chromatography method]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2017; 35:220-223. [PMID: 28511313 DOI: 10.3760/cma.j.issn.1001-9391.2017.03.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Objective: To establish ion chromatography method to determine thiocyanate within urine of workers who were exposed to cyanide. Methods: After the workers work, used 50 ml centrifuge tube to collect the urine of workers about 20 ml.The urine were tested by centrifugation, dilution and filtration by C(18) column, thiocyanate was separated by AS(16) and mobile phase elution by KOH, detected by electrical circuitryconductivity detector, quantitative by the standard curve method. Results: The linear correlation coefficient of thiocyanate within the range of 0.1-5.0 μg/ml was more than 0.999. The method detection limit was 0.11μg/ml (in 1ml urine) , the method quantitative limit was 0.35 μg/ml. The method recoveries were 95.1%-99.7%. The within-day precision range was 0.54%-2.05%, The between-run precision range was 2.06%-5.09%. Sample stability test showed that thiocyanate samples could be stored for 5 days at room temperature and 7 days at 4 ℃, could be stored for 14 days at-20 ℃. Conclusion: The technical indicator of method compliance with rule of Guide for establishing occupation health standards-Part 5: determination methods of chemicals in biological materials (GBZ/T 210.5-2008) , the method applies to workers who were exposed to cyanide.
Collapse
Affiliation(s)
- S Wang
- National Institute of Occupational Health and Poison Control, China CDC, Beijing 100050, China
| | | | | | | |
Collapse
|
235
|
Wei PH, Wang Y, Li H, Dou R, Li LY, Zhao W, Zhang JM. [Effect of optical zone diameter on corneal biomechanical properties after small incision lenticule extraction]. Zhonghua Yan Ke Za Zhi 2017; 53:182-187. [PMID: 28316192 DOI: 10.3760/cma.j.issn.0412-4081.2017.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the effect of optical zone diameter on corneal biomechanical properties after small incision lenticule extraction (SMILE). Methods: In this prospective case-control study, 62 eyes of 42 patients with myopia and myopic astigmatism that had undergone SMILE procedure were divided into 2 groups according to the optical zone (OZ) diameter: group A, 31 eyes of 19 patients, OZ= 6.5 mm; group B, 31eyes of 23 patients, OZ=6.0 mm. These patients were examined for corneal hysteresis (CH) and corneal resistance factor (CRF) with the Ocular Response Analyzer (ORA) preoperatively and at 1 week, 1 month and 3 months postoperatively; at the same time, the central corneal thickness-corrected indices of DifCH and DifCRF were calculated. Pearson correlation was applied to analyze the correlation between CH and CRF and central corneal thickness. Independent-samples t test was utilized to compare CH and CRF between the two groups. Repeated ANOVA was used to compare the difference of corneal biomechanical properties at different follow-up timepoints. Results: The preoperative mean CRF and CH values were (10.13±1.19) mmHg and (9.65±1.12) mmHg in group A and (10.34±0.89) mmHg and (10.04± 1.05) mmHg in group B, respectively, and no significant differences were found in CRF and CH between the two groups (CRF: t=-0.807, P=0.423. CH: t=-1.405, P=0.165). The mean CRF values in group A at postoperative 1 week and 3 months were (6.62 ± 1.09) mmHg and (6.83 ± 1.07) mmHg, respectively, which were significantly lower than the relevant mean CRF values in group B (t=-2.703, P=0.009. t=-3.733, P= 0.001). Meanwhile, the mean CH values at 1 week, 1 month and 3 months postoperatively in group A were (7.31±1.06) mmHg, (7.37±0.96) mmHg and (7.82±0.97) mmHg, respectively, which were significantly lower than those in group B (t=-2.415, P=0.019. t=-2.113, P=0.039. t=-2.67, P=0.01). Moreover, the DifCRF and DifCH values in group A were significantly lower than those in group B at 3 months postoperatively (t=-3.409, P=0.001. t=-2.064, P=0.044). The CRF and CH values in both groups showed a significant reduction at 1 week, 1 month and 3 months postoperatively (P<0.05). Conclusions: The size of optical zone has some effects on corneal biomechanical properties after SMILE. The smaller optical zone diameter has a relatively smaller effect. (Chin J Ophthalmol, 2017, 53:182-187).
Collapse
Affiliation(s)
- P H Wei
- Tianjin Medical University, Clinical College of Ophthalmology, Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin 300020, China
| | | | | | | | | | | | | |
Collapse
|
236
|
Zhao W, Zhao SP. [Update on the lipid management in patients with diabetes]. Zhonghua Xin Xue Guan Bing Za Zhi 2017; 45:96-98. [PMID: 28260311 DOI: 10.3760/cma.j.issn.0253-3758.2017.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
|
237
|
Zhao W, Li J, Lu Y, Akbani R, Liang H, Mills GB. Abstract P1-07-01: A pan-cancer perspective of functional proteomics provides novel information content for uncommon breast cancer subtypes. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p1-07-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Cancer cell lines (CCLs) serve as models to study the functional consequences of the genomic lesions in patients and as screening platforms for prediction of drug response. While genomic and transcriptomic data have proven to be useful predictors, the ability of these omics platforms to predict protein level and function is limited. Furthermore, since proteins are the targets of the majority of the targeted therapies, protein levels and importantly protein function would be expected to provide more powerful predictions than DNA or RNA data. While large scale genomic and transcriptomic data linked to drug sensitivity are available for over a thousand CCLs, proteomic data is available for only a small subset of lines. Here we performed proteomic profiling of 736 cell lines using reverse-phase protein arrays (RPPAs) with approximately 300 antibodies providing an unbiased sparse representation of the majority of signaling pathways.
The functional proteomic analysis revealed 10 protein-based clusters across all cell lines. Similar to human tumors, the breast cell lines fell into three major clusters representing basal-like, luminal/Her2-amplified and claudin-low breast cancer subtypes. The basal-like and claudin-low clusters contained all of the representative breast cancer cell lines as well as a much larger number of other CCLs. For example, the 6 claudin-low breast cancers analyzed reside in an EMT cluster, in which only 8/126 are breast cell lines. However, the complete cluster including multiple non-breast cancer cell lines recapitulated mRNA and protein features of claudin-low breast tumors, including a high EMT signature and low level of hormone receptor pathway activity. We thus explored whether we could gain power for linking the limited number of basal and claudin-low breast cancer cell lines to therapeutic sensitivity by assessing patterns of drug sensitivity in each cluster for both the breast and non-breast cancer cell lines in the cluster. We explored drug sensitivity of 481 therapeutic compounds from the Cancer Therapeutic Response Portal (CTRP v2) and demonstrated that the non- breast cancer and breast cancer cell lines in each cluster provided similar patterns of drug sensitivity. For example, Claudin-low/EMT cell lines of both breast cancer and non-breast cancer origin showed decreased sensitivity to PI3K/mTOR inhibitors compared to luminal breast cancers (p<0.05 for 4 mTOR inhibitors) and drugs targeting EGFR family compared to basal cell lines (p<0.05 for 7 EGFR/ERBB2 inhibitors). Thus it is possible to gain information by characterizing cell lines with similar patterns of protein expression and provide important information related to drug sensitivity of uncommon breast cancer lineages. The functional proteomic analysis provides a wealth of information that complements the genomic and transciptomic studies of cancer cell lines, and demonstrates the opportunity to leverage cell line 'pan-cancer' proteomic patterns to improve characterization of specific breast cancer subtypes. To facilitate broad access to these data, we developed a user-friendly data portal, the MD Anderson Cell Lines Project (MCLP), that provides both data analysis and download (http://ibl.mdanderson.org/mclp/).
Citation Format: Zhao W, Li J, Lu Y, Akbani R, Liang H, Mills GB. A pan-cancer perspective of functional proteomics provides novel information content for uncommon breast cancer subtypes [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P1-07-01.
Collapse
Affiliation(s)
- W Zhao
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - J Li
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Y Lu
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - R Akbani
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - H Liang
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - GB Mills
- The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
238
|
Haugen MH, Lindgjærde OC, Krohn M, Zhao W, Lindholm EM, Silwal-Pandit L, Borgen E, Garred Ø, Fangberget A, Holmen MM, Schlichting E, Skjerven H, Lundgren S, Wist E, Naume B, Mælandsmo GM, Lu Y, Børresen-Dale AL, Mills GB, Engebråten O. Abstract P6-13-01: Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - A randomized phase II study. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-13-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND: Patients with HER2 negative primary tumors of ≥25 mm were treated with neoadjuvant chemotherapy (4 x FEC100 + 12 weeks of taxane-based therapy) and randomized (1:1) to receive bevacizumab or not. Mammography, ultrasound and MR imaging were used for response evaluation, in addition to the final pathology assessment after surgery.
HYPOTHESIS: RPPA proteomic analyses support identification of molecular mechanisms associated with clinical response to bevacizumab treatment.
METHODS: Tumor responses were evaluable in 132 patients; of which 66 received bevacizumab. Ratio of the tumor size at final pathology assessment, and at inclusion was calculated to obtain a continuous scale of response reflecting the percentage of tumor shrinkage in response to therapy. Tumor material was obtained at screening, 12 weeks into treatment and at surgical removal of tumors at 25 weeks. Lysates from each sample was analyzed on reverse phase protein arrays (RPPA) for expression levels of 210 proteins of which 54 were phospho-specific.
RESULTS: Several proteins were found for which expression prior to treatment reflected a better response on tumor shrinkage in the combination treatment arm (chemotherapy+bevacizumab). The proteomic response from week 0 to 12 in both treatment arms had an overall similar profile regarding up- and down-regulated proteins; however, the combination treatment (FEC100 + bevacizumab) induced a more pronounced effect on regulation of each protein. This might reflect the capability of bevacizumab therapy to potentiate the effects of the anthracyclin based chemotherapy from week 0 to 12. Conversely, from week 12-25 (taxane-based therapy + bevacizumab) this effect was lost or even reversed, except for certain phosphoproteins where potentiation imposed by bevacizumab was sustained throughout the whole treatment period. We are in the process of analyzing the impact of phosphorylation and thus protein activation states on treatment response. Furthermore, tumors with low hormone receptor pathway score demonstrated a better response in the combination treatment (chemotherapy+bevacizumab). Additionally, in these good responders the hormone signaling pathway was significantly upregulated during treatment. Further investigations are conducted to determine if this was due to selective ablation of hormone receptor negative tumor cells, or a re-programming of the molecular phenotype of cells present prior to treatment. The above mentioned results have potentially important clinical relevance and will be further investigated with respect to subtypes and the biological pathways affected by antiangiogenic therapy.
Citation Format: Haugen MH, Lindgjærde OC, Krohn M, Zhao W, Lindholm EM, Silwal-Pandit L, Borgen E, Garred Ø, Fangberget A, Holmen MM, Schlichting E, Skjerven H, Lundgren S, Wist E, Naume B, Mælandsmo GM, Lu Y, Børresen-Dale A-L, Mills GB, Engebråten O. Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - A randomized phase II study [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P6-13-01.
Collapse
Affiliation(s)
- MH Haugen
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - OC Lindgjærde
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - M Krohn
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - W Zhao
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - EM Lindholm
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - L Silwal-Pandit
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - E Borgen
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - Ø Garred
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - A Fangberget
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - MM Holmen
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - E Schlichting
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - H Skjerven
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - S Lundgren
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - E Wist
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - B Naume
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - GM Mælandsmo
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - Y Lu
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - A-L Børresen-Dale
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - GB Mills
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| | - O Engebråten
- Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; MD Anderson Cancer Center, Houston, TX; Vestre Viken Hospital Trust, Drammen, Norway; St. Olavs Hospital, Trondheim, Norway
| |
Collapse
|
239
|
Luo X, Li B, Zhang X, Zhao W, Bratasz A, Deng B, McComb DW, Dong Y. Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents. Nanoscale 2017; 9:1575-1579. [PMID: 28067926 PMCID: PMC5316423 DOI: 10.1039/c6nr08496f] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Multi-functional nanomaterials possess unique properties, facilitating both therapeutic and diagnostic applications among others. Herein, we developed dual-functional lipid-like nanoparticles for simultaneous delivery of mRNA and magnetic resonance imaging (MRI) contrast agents in order to express functional proteins and provide real-time visualization. TT3-Gd18 LLNs were identified as a lead formulation, which was able to encapsulate 91% of mRNA and 74% of Gd. This formulation showed a comparable or a slightly higher delivery efficiency of mRNA compared to the initial TT3 LLNs. Moreover, a strong MRI signal was observed in the cell pellets treated with TT3-Gd18 LLNs. More importantly, TT3-Gd18 LLNs demonstrated an efficient delivery of mRNA and Gd contrast agents in vivo.
Collapse
Affiliation(s)
- X Luo
- Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.
| | - B Li
- Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.
| | - X Zhang
- Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.
| | - W Zhao
- Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.
| | - A Bratasz
- Small Animal Imaging Center, The Ohio State University, Columbus, Ohio 43210, USA
| | - B Deng
- Center for Electron Microscopy and Analysis, Department of Materials Science and Engineering, The Ohio State University, Columbus, Ohio 43210, USA
| | - D W McComb
- Center for Electron Microscopy and Analysis, Department of Materials Science and Engineering, The Ohio State University, Columbus, Ohio 43210, USA
| | - Y Dong
- Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.
| |
Collapse
|
240
|
Zhao W, Sun C, Cui Z. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma. Clin Transl Oncol 2017; 19:735-741. [PMID: 28105536 DOI: 10.1007/s12094-016-1597-7] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Accepted: 12/10/2016] [Indexed: 11/29/2022]
Abstract
BACKGROUND Acting as a proto-oncogene, long noncoding RNAs (lncRNAs) urothelial carcinoembryonic antigen 1 (UCA1) plays a key role in the occurrence and development of several human tumors. However, the expression and biological functions of UCA1 in glioma are less known. This study discussed the expression of UCA1 in glioma and its effect on the proliferation and cell cycle of glioma cells. METHOD LncRNA UCA1 expressions in 64 glioma samples (Grade I-II in 22 cases and Grade III-IV in 42 cases, according to WHO criteria) and 10 normal brain samples were detected using real-time fluorescence quantitative PCR. On this basis, the correlations of UCA1 to clinicopathological characteristics and prognosis of glioma were assessed. Then, using qPCR, the lncRNA UCA1 expressions in glioma cell lines and astrocytes were detected. UCA1-overexpressing glioma cell lines U87 and U251 were further detected after siRNA transfection of these two cell lines, and the impact on cell proliferation and cell cycle was assessed with CCK-8 (cell counting kit-8) assay and flow cytometry method (FCM), respectively. The expression of cyclin D1, a cell cycle-related protein, was detected using Western Blot. RESULT LncRNA UCA1 expression in the glioma samples was obviously higher as compared with the normal brain samples (P < 0.001), and the expression was correlated significantly with grading of the tumors (P < 0.05). However, lncRNA UCA1 expression was not correlated with age, gender, tumor size and KPS score (P > 0.05). After interference of UCA1 expression by siRNA transfection, the proliferation of both U251 and SHG-44 cells was inhibited (P < 0.05), with more cells arrested in G0/G1 (P < 0.05). Moreover, cyclin D1 expression was also downregulated considerably. CONCLUSION LncRNA UCA1 can promote the proliferation and cell cycle progression of glioma cells by upregulating cyclin D1 transcription. So UCA1 may serve as an independent prognostic indicator and a novel therapeutic target for glioma.
Collapse
Affiliation(s)
- W Zhao
- Department of Neurosurgery, The Affiliated 2ed Hospital of Nantong University, 6 Baby Lane North Road, Nantong, 226001, Jiangsu, China
| | - C Sun
- Department of Neurosurgery, Zhejiang Cancer Hospital, 38 Guangji Road, Hangzhou, 310022, Zhejiang, China.
| | - Z Cui
- Department of Neurosurgery, The Affiliated 2ed Hospital of Nantong University, 6 Baby Lane North Road, Nantong, 226001, Jiangsu, China.
| |
Collapse
|
241
|
Wu N, Qin H, Wang M, Bian Y, Dong B, Sun G, Zhao W, Chang G, Xu Q, Chen G. Variations in endothelin receptor B subtype 2 (EDNRB2) coding sequences and mRNA expression levels in 4 Muscovy duck plumage colour phenotypes. Br Poult Sci 2017; 58:116-121. [DOI: 10.1080/00071668.2016.1259531] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- N. Wu
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, People’s Republic of China
| | - H. Qin
- National Waterfowl Germplasm Resource Pool, Taizhou, People’s Republic of China
| | - M. Wang
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, People’s Republic of China
| | - Y. Bian
- National Waterfowl Germplasm Resource Pool, Taizhou, People’s Republic of China
| | - B. Dong
- National Waterfowl Germplasm Resource Pool, Taizhou, People’s Republic of China
| | - G. Sun
- National Waterfowl Germplasm Resource Pool, Taizhou, People’s Republic of China
| | - W. Zhao
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, People’s Republic of China
| | - G. Chang
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, People’s Republic of China
| | - Q. Xu
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, People’s Republic of China
| | - G. Chen
- Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, People’s Republic of China
| |
Collapse
|
242
|
Zhao W, Zhou X, Kim IJ, Kim S. Self-assembled Co 3O 4 hexagonal plates by solvent engineering and their dramatically enhanced electrochemical performance. Nanoscale 2017; 9:940-946. [PMID: 28000834 DOI: 10.1039/c6nr07871k] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
In this study, a facile two-phase solvothermal method was used to synthesize Co3O4 nanocubes with high crystallinity and narrow size distribution (∼49 nm) for use in lithium-ion batteries. Here, oleylamine (OAm) was chosen as the solvent, surfactant, and reducing agent. After washing with the appropriate organic solvent, the Co3O4 nanocubes self-assembled into hexagonal plates with a diameter and thickness of approximately 2.5 μm and 550 nm, respectively. Moreover, with the assistance of dipole-dipole and van der Waals interactions, the Co3O4 nanocubes stacked along the [111] direction with their exposed facets attached, leading to their final exposed cross-sectional facet being (111). A possible assembling mechanism is proposed and explained in detail. Furthermore, the self-assembled (111) faceted Co3O4 plates exhibited superior electrochemical capacity and stability to those original (001) faceted Co3O4 nanocubes for Li+ ion storage. Therefore, the solvent engineered self-assembly into secondary structures has proven to be a potential strategy for energy applications.
Collapse
Affiliation(s)
- W Zhao
- School of Materials Science and Engineering, Yeungnam University, Gyeongsan city, Gyeongbuk 712-749, Republic of Korea.
| | - X Zhou
- School of Materials Science and Engineering, Yeungnam University, Gyeongsan city, Gyeongbuk 712-749, Republic of Korea. and Division of Functional Materials and Nanodevices, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, P. R. China
| | - I Jin Kim
- Department of Materials Science and Engineering, Hanseo University, Seosan, Chungnam 31962, Republic of Korea
| | - S Kim
- School of Materials Science and Engineering, Yeungnam University, Gyeongsan city, Gyeongbuk 712-749, Republic of Korea.
| |
Collapse
|
243
|
Shi H, Zhang C, Zhao W, Luo J, Loor J. Peroxisome proliferator-activated receptor delta facilitates lipid secretion and catabolism of fatty acids in dairy goat mammary epithelial cells. J Dairy Sci 2017; 100:797-806. [DOI: 10.3168/jds.2016-11647] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Accepted: 09/22/2016] [Indexed: 12/20/2022]
|
244
|
Abstract
Activation of chrysocolla by organic Cu-chelating agents was studied using a series of test and analysis methods, revealing that the performance of these agents was related to their chemical activity and chrysocolla dissolution properties.
Collapse
Affiliation(s)
- D. Jiang
- School of Materials Science and Engineering
- Shanghai University
- Shanghai 200072
- China
| | - J. Lan
- Shanghai Film Academy
- Shanghai University
- Shanghai 200072
- China
| | - W. Zhao
- Kunming Professional College of Arts
- Kunming 650073
- China
| | | | - Y. Lan
- Yunnan University
- Kunming 650091
- China
| |
Collapse
|
245
|
Yin Z, Fei Z, Qiu C, Brasher MS, Kraus VB, Zhao W, Shi X, Zeng Y. Dietary Diversity and Cognitive Function among Elderly People: A Population-Based Study. J Nutr Health Aging 2017; 21:1089-1094. [PMID: 29188865 PMCID: PMC5726290 DOI: 10.1007/s12603-017-0912-5] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
OBJECTIVES To explore associations of dietary diversity with cognitive function among Chinese elderly. DESIGN This cross-sectional study was conducted in 2011-2012, data were analyzed using multiple linear regression and logistic regression models. SETTING community-based setting in the 23 provinces in China. SUBJECTS 8,571 elderly participants, including 2984 younger elderly aged 65-79 and 5587 oldest old aged 80+ participated in this study. MEASUREMENT Intake frequencies of food groups was collected and dietary diversity (DD) was assessed based on the mean of DD score. Cognitive function was assessed using the Chinese version of Mini-Mental State Examination (MMSE), and cognitive impairment was defined using education-based cutoffs. Information about socio-demographics, lifestyles, resilience and health status was also collected. RESULTS Poor dietary diversity was significantly associated with cognitive function, with β (95% CI) of -0.11(-0.14, -0.08) for -log (31-MMSE score) and odds ratio (95% CI) of 1.29 (1.14, 1.47) for cognitive impairment. Interaction effect of age with DD was observed on cognitive impairment (P interaction=0.018), but not on -log (31-MMSE score) (P interaction=0.08). Further separate analysis showed that poor DD was significantly associated with increased risk of cognitive impairment in the oldest old (p<0.01), with odds ratio (95% CI) of 1.34 (1.17, 1.54), while not in the younger elderly (p>0.05), with OR (95% CI) being 1.09 (0.80, 1.47) in the fully adjusted model. Similar results were obtained when DD was categorized into four groups. CONCLUSIONS Poor dietary diversity was associated with worse global cognitive function among Chinese elderly, and particularly for the oldest old. This finding would be very meaningful for prevention of cognitive impairment.
Collapse
Affiliation(s)
- Z Yin
- Dr. Wenhua Zhao, Xiaoming Shi and Yi Zeng are co-corresponding authors. Please send email to Dr. Wenhua Zhao, 27 Nanwei Road, Xi Cheng District, Beijing 100050, China. Tel.: 86-10-66237006,
| | | | | | | | | | | | | | | |
Collapse
|
246
|
Clark AM, Wheeler SE, Young CL, Stockdale L, Shepard Neiman J, Zhao W, Stolz DB, Venkataramanan R, Lauffenburger D, Griffith L, Wells A. A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties. Lab Chip 2016; 17:156-168. [PMID: 27910972 PMCID: PMC5242229 DOI: 10.1039/c6lc01171c] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Distant metastasis is the major cause of breast cancer-related mortality, commonly emerging clinically after 5 or more years of seeming 'cure' of the primary tumor, indicating a quiescent dormancy. The lack of relevant accessible model systems for metastasis that recreate this latent stage has hindered our understanding of the molecular basis and the development of therapies against these lethal outgrowths. We previously reported on the development of an all-human 3D ex vivo hepatic microphysiological system that reproduces several features of liver physiology and enables spontaneous dormancy in a subpopulation of breast cancer cells. However, we observed that the dormant cells were localized primarily within the 3D tissue, while the proliferative cells were in contact with the polystyrene scaffold. As matrix stiffness is known to drive inflammatory and malignant behaviors, we explored the occurrence of spontaneous tumor dormancy and inflammatory phenotype. The microphysiological system was retrofitted with PEGDa-SynKRGD hydrogel scaffolding, which is softer and differs in the interface with the tissue. The microphysiological system incorporated donor-matched primary human hepatocytes and non-parenchymal cells (NPCs), with MDA-MB-231 breast cancer cells. Hepatic tissue in hydrogel scaffolds secreted lower levels of pro-inflammatory analytes, and was more responsive to inflammatory stimuli. The proportion of tumor cells entering dormancy was markedly increased in the hydrogel-supported tissue compared to polystyrene. Interestingly, an unexpected differential response of dormant cells to varying chemotherapeutic doses was identified, which if reflective of patient pathophysiology, has important implications for patient dosing regimens. These findings highlight the metastatic microphysiological system fitted with hydrogel scaffolds as a critical tool in the assessment and development of therapeutic strategies to target dormant metastatic breast cancer.
Collapse
Affiliation(s)
- A M Clark
- Department of Pathology, University of Pittsburgh, S711 Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261, USA.
| | - S E Wheeler
- Department of Pathology, University of Pittsburgh, S711 Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261, USA.
| | - C L Young
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - L Stockdale
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - J Shepard Neiman
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - W Zhao
- Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA
| | - D B Stolz
- Department of Pathology, University of Pittsburgh, S711 Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261, USA. and Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA and University of Pittsburgh Cancer Center, Pittsburgh, PA, USA
| | - R Venkataramanan
- Department of Pathology, University of Pittsburgh, S711 Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261, USA. and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA
| | - D Lauffenburger
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - L Griffith
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - A Wells
- Department of Pathology, University of Pittsburgh, S711 Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261, USA. and Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA and Pittsburgh VA Medical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| |
Collapse
|
247
|
Choo B, Lee Z, Zhao W, Wang X, Ng J, Low J, Deng L. 326P Biomarker discovery for early prediction of therapy resistance in cervical cancers. Ann Oncol 2016. [DOI: 10.1016/s0923-7534(21)00484-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
248
|
Choo B, Lee Z, Zhao W, Wang X, Ng J, Low J, Deng L. 326P Biomarker discovery for early prediction of therapy resistance in cervical cancers. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw585.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
249
|
Qin W, Zhao W, Li X, Peng Y, Harlow LM, Li J, Qin Y, Pan J, Wu Y, Ran L, Ke HZ, Cardozo CP, Bauman WA. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury. Osteoporos Int 2016; 27:3627-3636. [PMID: 27436301 DOI: 10.1007/s00198-016-3700-x] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2016] [Accepted: 07/01/2016] [Indexed: 12/11/2022]
Abstract
UNLABELLED Bone loss after spinal cord injury (SCI) is rapid, severe, and refractory to interventions studied to date. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by SCI, further indicating pharmacological inhibition of sclerostin may represent a promising novel approach to this challenging medical problem. INTRODUCTION The bone loss secondary to spinal cord injury (SCI) is associated with several unique pathological features, including the permanent immobilization, neurological dysfunction, and systemic hormonal alternations. It remains unclear how these complex pathophysiological changes are linked to molecular alterations that influence bone metabolism in SCI. Sclerostin is a key negative regulator of bone formation and bone mass. We hypothesized that sclerostin could function as a major mediator of bone loss following SCI. METHODS To test this hypothesis, 10-week-old female sclerostin knockout (SOST KO) and wild type (WT) mice underwent complete spinal cord transection or laminectomy (Sham). RESULTS At 8 weeks after SCI, substantial loss of bone mineral density was observed at the distal femur and proximal tibia in WT mice but not in SOST KO mice. By μCT, trabecular bone volume of the distal femur was markedly decreased by 64 % in WT mice after SCI. In striking contrast, there was no significant reduction of bone volume in SOST KO/SCI mice compared with SOST KO/sham. Histomorphometric analysis of trabecular bone revealed that the significant reduction in bone formation rate following SCI was observed in WT mice but not in SOST KO mice. Moreover, SCI did not alter osteoblastogenesis of marrow stromal cells in SOST KO mice. CONCLUSION Our findings demonstrate that SOST KO mice were protected from the major sublesional bone loss that invariably follows SCI. The evidence indicates that sclerostin is an important mediator of the marked sublesional bone loss after SCI, and that pharmacological inhibition of sclerostin may represent a promising novel approach to this challenging clinical problem.
Collapse
Affiliation(s)
- W Qin
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA.
- Departments of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| | - W Zhao
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
| | - X Li
- Amgen Inc, Thousand Oaks, CA, USA
| | - Y Peng
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
| | - L M Harlow
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
| | - J Li
- Indiana University Purdue University, Indianapolis, IN, USA
| | - Y Qin
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
| | - J Pan
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
| | - Y Wu
- Departments of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Institute of Gene Engineering Animal Models for Human Diseases, Dalian Medical University, Dalian, China
| | - L Ran
- Institute of Gene Engineering Animal Models for Human Diseases, Dalian Medical University, Dalian, China
| | | | - C P Cardozo
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
- Departments of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - W A Bauman
- National Center for the Medical Consequences of SCI, James J. Peters VA Medical Center, 130 West Kingsbridge Roa, Bronx, NY, 10468, USA
- Departments of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
250
|
Chen X, Li L, You Y, Mao B, Zhao W, Zhan J. The Effects of Ultra-high Pressure Treatment on the Phenolic Composition of Red Wine. S AFR J ENOL VITIC 2016. [DOI: 10.21548/33-2-1120] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|